跳至主要内容
临床试验/NCT02756403
NCT02756403已完成不适用

A Randomized Controlled Trial of Three Prophylactic Antibiotic Regimens for First Trimester Surgical Abortion

Medstar Health Research Institute2 个研究点 分布在 1 个国家目标入组 181 人开始时间: 2016年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
181
试验地点
2
主要终点
Nausea Scale

研究概览

简要总结

This study, a double blinded randomized controlled trial, is being done to compare side effects of commonly used antibiotic regimens prior to same day abortion procedures.

In total, 180 pregnant women in their first trimester of pregnancy (5 0/6-13 6/7 weeks gestation) will be randomized to receive one of the three commonly used antibiotics (azithromycin, doxycycline, metronidazole) for same day abortion procedures or placebo prior to their abortion procedure. Approximately, 30-60 mins after study drug administration, the procedure will be performed.

A sub-study will be completed on 40 women who consent to endometrial sampling and to have their blood drawn.

详细描述

Main Study:

Women will be randomized to receive single oral doses of azithromycin 500 mg, doxycycline 200 mg, metronidazole 500 mg, or placebo. Computer-generated randomization will be used to assign participants to one of the four treatment arms. Women receiving placebo will receive antibiotic prophylaxis after completion of the study.

Both the participants and the investigators will be blinded as to the treatment group. This will be accomplished by placing the study medication inside opaque gelatin capsules. We will randomize participants by assigning them to the next of the sequentially numbered sealed opaque study packets, containing the gelatin capsules with study medication inside. A second envelope will be opened after completion of all study procedure and will only say if the participant received placebo, so that additional antibiotics can be given.

Participants will swallow the appropriate medication approximately 30-60 minutes prior to the surgical abortion (15-90 minutes range is acceptable). Study population will be all eligible patients undergoing surgical abortion in the first trimester at Washington Hospital Center and Planned Parenthood Metropolitan Washington. We will assess pain and side effects via written questionnaire at three different time points throughout the day, once at time of consent, before and after the procedure. Patients will be contacted within 1-2 weeks for follow-up and again pain and side effects will be assessed, as well.

Sub-study:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women in good general health.
  • English speaking.
  • Age 18 or over.
  • Seeking non-urgent surgical termination of pregnancy.
  • Gestational age of 5 0/7 to 13 6/7 weeks, confirmed by sonogram.

排除标准

  • Less than 18 years of age.
  • Early pregnancy failure or fetal demise.
  • Poor general health that would prevent one from tolerating the medication or surgical procedure.
  • Intolerance, allergy, or contraindication to any of the study medications.
  • Inability to tolerate oral intake due to current nausea or vomiting.
  • Diagnosis of hyperemesis gravidarum with current pregnancy.
  • Need of an urgent surgical abortion.
  • Gestational age outside of 5-13 6/7 weeks by sonogram.

研究组 & 干预措施

Azithromycin

Active Comparator

500 mg of Azithromycin

干预措施: Azithromycin (Drug)

Doxycycline

Active Comparator

200 mg of Doxycycline

干预措施: Doxycycline (Drug)

Metronidazole

Active Comparator

500 mg of Metronidazole

干预措施: Metronidazole (Drug)

Placebo

Placebo Comparator

Inactive Ingredient

干预措施: Placebo (Drug)

结局指标

主要结局

Nausea Scale

时间窗: 1 Day

Nausea symptom was collected at different time points via surveys (None, Mild, Moderate, Severe)

Emesis Severity

时间窗: 1 Day

Emesis severity assessment collected at different time points (None, Mild, Moderate, Severe)

次要结局

  • Serum Antibiotic Levels(3 hours)
  • Pain Scale(Day 1)
  • Endometrial Growth(3 Days)

研究者

发起方
Medstar Health Research Institute
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验